ARCHIVES

Beckman Coulter Offers Immunoassay System.

This article is from The Cancer Letter archive.

Vol. 27 No. 30 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

House Passes Cancer Act Renewal With Provision Permitting NCI To Reinstate Training Program

May 10, 1974

GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer.

November 2, 2007

Aggressive Cancer Screening Increases Overdiagnosis, JAMA Paper Argues

October 30, 2009

Statins Associated With Lower Risk Of High-Grade Prostate Cancer

March 25, 2011

FDA Advisors Recommend Approval Of Taxol for Node-Positive Breast Cancer

September 24, 1999

NCI Remains Exception To NIH Authority Over Scientific Counselors

January 27, 1995